Prosecution Insights
Last updated: October 25, 2026

Cosud Intellectual Property Solutions, P.C.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics

5 pending office actions • 4 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready

Analysis

COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C. focuses on Biotechnology & Pharmaceuticals. The profile records 5 pending office actions and 1285 career applications, showing a relatively limited current workload within a substantial historical prosecution record.

The resolved allowance rate is 79.35%, with an average of 3.02 office actions per allowance. The figures indicate that resolved outcomes include a meaningful allowance result while often involving several examination exchanges. Practitioners can use the aggregate data as context, but should assess claim scope and amendment history in each active matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1285 apps, methodology: how we score firms)

79.4%
Allowance Rate
n=1285
+0.68σ
Allowance Rate (norm)
n=1285
3.0
OAs to Allowance
n=753
-0.34σ
OAs to Allow (norm)
n=753
1051 days
Time to Allowance
n=753
+13.7pp
Interview Lift
n=1285
15.9%
RCE Rate
n=1285
1.9%
Appeal Rate
n=1285

Rejection Performance (% of received rejections ultimately overcome)

89.4%
§101 Overcome
n=47
75.6%
§102 Overcome
n=275
77.1%
§103 Overcome
n=450
83.5%
§112 Overcome
n=478

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
31%
Top-3 CPC Share
n=1285
1
Practitioners
n=1285
1285.0
Apps / Practitioner
n=1285

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (40%)
Multi-statute (no §101)3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
20% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOLLINGTON, JERMELE M 1 86.3% -15.3%
PIPIC, ALMA 1 54.8% +54.3%
WITTENBERG, STEFANIE S 1 54.6% +17.6%
NGUYEN, JOHN P 1 43.9% +41.8%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.3% +39.1%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18888510 ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS HOLLINGTON, JERMELE M —
18775053 Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions PIPIC, ALMA —
18282837 Dynamic Glass Element Using Reversible Metal Electrodeposition Electrolytes with Tunable PH with High Opacity and Excellent Resting Stability and Electrolytes Useful Therefore WITTENBERG, STEFANIE S —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18775053 Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions PIPIC, ALMA —
18282837 Dynamic Glass Element Using Reversible Metal Electrodeposition Electrolytes with Tunable PH with High Opacity and Excellent Resting Stability and Electrolytes Useful Therefore WITTENBERG, STEFANIE S —
18073852 DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS NGUYEN, JOHN P —
17801486 TREATMENT FOR CHEMOBRAIN ABDALHAMEED, MANAHIL MIRGHANI ALI —

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
28581
16171
17951
16191
16221

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18888510 ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS UNM RAINFOREST INNOVATIONS HOLLINGTON, JERMELE M 2858 §102§103§112 Non-Final OA — Pending Sep 18, 2024
18775053 Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions The United States Department of Veterans Affairs PIPIC, ALMA 1617 §102§103§112 Non-Final OA — Pending Jul 17, 2024
18282837 Dynamic Glass Element Using Reversible Metal Electrodeposition Electrolytes with Tunable PH with High Opacity and Excellent Resting Stability and Electrolytes Useful Therefore The Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada WITTENBERG, STEFANIE S 1795 §103§112 Non-Final OA — Pending Sep 19, 2023
18073852 DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS Yale University NGUYEN, JOHN P 1619 §103 Non-Final OA — Pending Dec 02, 2022
17801486 TREATMENT FOR CHEMOBRAIN Yale University ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103 Final Rejection — Pending Aug 22, 2022

Managing Cosud Intellectual Property Solutions, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Cosud Intellectual Property Solutions, P.C.'s patent allowance rate?

79.3% of resolved applications prosecuted by Cosud Intellectual Property Solutions, P.C. were allowed, across 1,285 applications in USPTO records.

How many office actions does Cosud Intellectual Property Solutions, P.C. average before allowance?

3.02 office actions per allowed application on average.

How many pending office actions does Cosud Intellectual Property Solutions, P.C. have?

5 pending office actions as of October 2026, for 4 clients, before 5 examiners in 5 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month